This site is intended for health professionals only
GMC alert on private screening tests
GPs who recommend screening tests offered by private firms to their patients could fall foul of the GMC under new guidance issued by the National Screening Committee.
16 February 2010
RCGP set for female chair
Exclusive: The RCGP looks set to have its first female leader in recent years, with two women the frontrunners in the race to replace Professor Steve Field as chair.
16 February 2010
Figures reveal thousands of assaults on GPs and staff
There were nearly 3,500 assaults on GPs and primary care staff recorded last year, according to the latest Department of Health figures.
15 February 2010
Waist measure reliable in different ethnic groups
Waist circumference is an accurate predictor of metabolic syndrome in both white and south Asian patients, say UK GP researchers.
15 February 2010
Nottingham eczema severity score
The Nottingham eczema severity score provides an simple, objective assessment of the clinical severity of atopic eczema.
15 February 2010
NICE draft appraisal approves liraglutide for type 2 diabetes
NICE has recommended liraglutide as an alternative to insulin in obese patients with uncontrolled glucose levels.
15 February 2010
Virgin poised to swipe raft of Darzi centres
Richard’s Branson’s Virgin Healthcare is preparing to make a dramatic return to primary care with a deal which overnight would make it the biggest provider of Darzi centres in the country, according to reports circulating in the City.
12 February 2010
BMA launches major public campaign against private sector
The BMA has launched a major fight-back against the expansion of private sector provision in the NHS.
12 February 2010
Stop labelling GP referrals as ‘inappropriate’ says DH cancer tsar
Pressure on GPs by NHS managers to cut referral rates is damaging the drive to diagnose cancers earlier, says a top DH adviser.
12 February 2010
GPs advised against urine test for UTIs
GPs are being advised against the routine use of midstream urine test for women with uncomplicated urinary tract infections, after research found it did not improve symptom control but was the most expensive of five treatment strategies.
12 February 2010
